Summary of Study ST001751

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001114. The data can be accessed directly via it's Project DOI: 10.21228/M8Q39V This work is supported by NIH grant, U2C- DK119886.

See: https://www.metabolomicsworkbench.org/about/howtocite.php

This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.

Perform statistical analysis  |  Show all samples  |  Show named metabolites  |  Download named metabolite data  
Download mwTab file (text)   |  Download mwTab file(JSON)   |  Download data files (Contains raw data)
Study IDST001751
Study TitleFree fatty acid analysis of NIH-3T3 cells treated with apoptotic inducers
Study TypeTargeted lipidomics
Study SummaryChanges of free fatty acid profiles in mouse NIH-3T3 fibroblasts treated with mechanistically diverse apoptotic inducers for 48h.
Institute
University of Innsbruck
DepartmentMichael Popp Institute
Last NameKoeberle
First NameAndreas
AddressMitterweg 24, Innsbruck, Tyrol, 6020, Austria
Emailandreas.koeberle@uibk.ac.at
Phone+43 512 507 57903
Submit Date2021-04-02
Raw Data AvailableYes
Raw Data File Type(s)wiff
Analysis Type DetailLC-MS
Release Date2021-05-01
Release Version1
Andreas Koeberle Andreas Koeberle
https://dx.doi.org/10.21228/M8Q39V
ftp://www.metabolomicsworkbench.org/Studies/ application/zip

Select appropriate tab below to view additional metadata details:

Factors:

Subject type: Cultured cells; Subject species: Mus musculus (Factor headings shown in green)

mb_sample_id local_sample_id hours treatment concentration
SA163885VJ_17.05.17-n3_#21 - VJ_17.05.17_Kinase_screeneing_48h_n3_FFA_00548 CHX 20 µg/ml
SA163886VJ_17.05.13_2_#21 - VJ_17.05.13_Kinase_screeneing_48h_n1_FFA_00548 CHX 20 µg/ml
SA163887VJ_17.05.17_#21 - VJ_17.05.17_Kinase_screeneing_48h_n2_FFA_00548 CHX 20 µg/ml
SA163888VJ_17.05.17_#22 - VJ_17.05.17_Kinase_screeneing_48h_n2_FFA_00648 ETO 10 µM
SA163889VJ_17.05.13_2_#22 - VJ_17.05.13_Kinase_screeneing_48h_n1_FFA_00648 ETO 10 µM
SA163890VJ_17.05.17-n3_#22 - VJ_17.05.17_Kinase_screeneing_48h_n3_FFA_00648 ETO 10 µM
SA163891VJ_17.05.13_2_#27 - VJ_17.05.13_Kinase_screeneing_48h_n1_FFA_01148 I3M 10 µM
SA163892VJ_17.05.17_#27 - VJ_17.05.17_Kinase_screeneing_48h_n2_FFA_01148 I3M 10 µM
SA163893VJ_17.05.17-n3_#27 - VJ_17.05.17_Kinase_screeneing_48h_n3_FFA_01148 I3M 10 µM
SA163894VJ_17.05.17_#26 - VJ_17.05.17_Kinase_screeneing_48h_n2_FFA_01048 MC 10 µM
SA163895VJ_17.05.13_2_#26 - VJ_17.05.13_Kinase_screeneing_48h_n1_FFA_01048 MC 10 µM
SA163896VJ_17.05.17-n3_#26 - VJ_17.05.17_Kinase_screeneing_48h_n3_FFA_01048 MC 10 µM
SA163900VJ_17.05.17_#25 - VJ_17.05.17_Kinase_screeneing_48h_n2_FFA_00948 Serum -
SA163901VJ_17.05.17-n3_#25 - VJ_17.05.17_Kinase_screeneing_48h_n3_FFA_00948 Serum -
SA163902VJ_17.05.13_2_#25 - VJ_17.05.13_Kinase_screeneing_48h_n1_FFA_00948 Serum -
SA163897VJ_17.05.17-n3_#20 - VJ_17.05.17_Kinase_screeneing_48h_n3_FFA_00448 STS 0.3 µM
SA163898VJ_17.05.13_2_#20 - VJ_17.05.13_Kinase_screeneing_48h_n1_FFA_00448 STS 0.3 µM
SA163899VJ_17.05.17_#20 - VJ_17.05.17_Kinase_screeneing_48h_n2_FFA_00448 STS 0.3 µM
SA163903VJ_17.05.13_2_#19 - VJ_17.05.13_Kinase_screeneing_48h_n1_FFA_00348 TNFα 10 ng/ml
SA163904VJ_17.05.17-n3_#19 - VJ_17.05.17_Kinase_screeneing_48h_n3_FFA_00348 TNFα 10 ng/ml
SA163905VJ_17.05.17_#19 - VJ_17.05.17_Kinase_screeneing_48h_n2_FFA_00348 TNFα 10 ng/ml
SA163906VJ_17.05.17-n3_#23 - VJ_17.05.17_Kinase_screeneing_48h_n3_FFA_00748 TPG 2 µM
SA163907VJ_17.05.17_#23 - VJ_17.05.17_Kinase_screeneing_48h_n2_FFA_00748 TPG 2 µM
SA163908VJ_17.05.13_2_#23 - VJ_17.05.13_Kinase_screeneing_48h_n1_FFA_00748 TPG 2 µM
SA163909VJ_17.05.13_2_#24 - VJ_17.05.13_Kinase_screeneing_48h_n1_FFA_00848 VAL 10 µM
SA163910VJ_17.05.17-n3_#24 - VJ_17.05.17_Kinase_screeneing_48h_n3_FFA_00848 VAL 10 µM
SA163911VJ_17.05.17_#24 - VJ_17.05.17_Kinase_screeneing_48h_n2_FFA_00848 VAL 10 µM
SA163912VJ_17.05.17-n3_#28 - VJ_17.05.17_Kinase_screeneing_48h_n3_FFA_01248 vehicle (DMSO) -
SA163913VJ_17.05.17_#28 - VJ_17.05.17_Kinase_screeneing_48h_n2_FFA_01248 vehicle (DMSO) -
SA163914VJ_17.05.13_2_#28 - VJ_17.05.13_Kinase_screeneing_48h_n1_FFA_01248 vehicle (DMSO) -
SA163915VJ_17.05.17-n3_#18 - VJ_17.05.17_Kinase_screeneing_48h_n3_FFA_00248 vehicle (DMSO) -
SA163916VJ_17.05.17_#18 - VJ_17.05.17_Kinase_screeneing_48h_n2_FFA_00248 vehicle (DMSO) -
SA163917VJ_17.05.13_2_#18 - VJ_17.05.13_Kinase_screeneing_48h_n1_FFA_00248 vehicle (DMSO) -
Showing results 1 to 33 of 33
  logo